KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Ratio (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Equity Ratio for 4 consecutive years, with 0.62 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Equity Ratio fell 19.91% year-over-year to 0.62, compared with a TTM value of 0.62 through Sep 2023, down 19.91%, and an annual FY2022 reading of 0.68, down 9.65% over the prior year.
  • Equity Ratio was 0.62 for Q3 2023 at Ginkgo Bioworks Holdings, down from 0.66 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.79 in Q1 2022 and bottomed at 0.21 in Q2 2021.
  • Average Equity Ratio over 4 years is 0.62, with a median of 0.68 recorded in 2022.
  • The sharpest move saw Equity Ratio skyrocketed 243.76% in 2022, then dropped 19.91% in 2023.
  • Year by year, Equity Ratio stood at 0.7 in 2020, then grew by 8.71% to 0.76 in 2021, then fell by 9.65% to 0.68 in 2022, then fell by 9.59% to 0.62 in 2023.
  • Business Quant data shows Equity Ratio for DNA at 0.62 in Q3 2023, 0.66 in Q2 2023, and 0.67 in Q1 2023.